Literature DB >> 1937748

Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats.

H R Alexander1, G M Doherty, M I Block, P J Kragel, J C Jensen, H N Langstein, E Walker, J A Norton.   

Abstract

Tumor necrosis factor (TNF), a macrophage product released in response to endotoxin and other stimuli, has been shown to be a central mediator of endotoxin or septic shock. However, its highly conserved and wide-ranging physiological effects suggest that it may also be an essential cytokine in the host defense against acute bacterial infection or sepsis. A single nontoxic dose of human recombinant TNF administered intravenously 24 h prior to a lethal infusion of Escherichia coli lipopolysaccharide (LPS) completely prevented acute LPS-induced hypotension, ameliorated tissue injury in the lungs and liver, and improved survival in male Fisher 344 rats. The protective effects of TNF were dose dependent and required a 24-h pretreatment interval. After the infusion of LPS, animals in both groups (TNF-treated animals and saline-pretreated controls) initially appeared acutely ill and had a similar severe metabolic acidosis, indicating that TNF did not inactivate or prevent the toxic effects of LPS. Twelve hours after the administration of TNF, the gene for manganous superoxide dismutase, a mitochondrial enzyme which scavenges toxic reactive oxygen species and is induced during conditions which generate a free radical stress, was expressed in liver tissue, suggesting that the induction of manganous superoxide dismutase may be an important in vivo protective mechanism against cellular injury during lethal endotoxemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937748      PMCID: PMC258973          DOI: 10.1128/iai.59.11.3889-3894.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Molecular basis for tumor necrosis factor-induced increase in pulmonary superoxide dismutase activities.

Authors:  M F Tsan; J E White; C Treanor; J B Shaffer
Journal:  Am J Physiol       Date:  1990-12

2.  Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.

Authors:  H R Alexander; B C Sheppard; J C Jensen; H N Langstein; C M Buresh; D Venzon; E C Walker; D L Fraker; M C Stovroff; J A Norton
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

Review 4.  Aspects of the structure, function, and applications of superoxide dismutase.

Authors:  J V Bannister; W H Bannister; G Rotilio
Journal:  CRC Crit Rev Biochem       Date:  1987

5.  Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism.

Authors:  G H Wong; D V Goeddel
Journal:  Science       Date:  1988-11-11       Impact factor: 47.728

6.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

8.  Molecular cloning of the complementary DNA for human tumor necrosis factor.

Authors:  A M Wang; A A Creasey; M B Ladner; L S Lin; J Strickler; J N Van Arsdell; R Yamamoto; D F Mark
Journal:  Science       Date:  1985-04-12       Impact factor: 47.728

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity.

Authors:  D L Fraker; M C Stovroff; M J Merino; J A Norton
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  7 in total

1.  Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS).

Authors:  S S Qureshi; S M Lewis; V A Gant; D Treacher; B H Davis; K A Brown
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart.

Authors:  C Napoli; C Cicala; J L Wallace; F de Nigris; V Santagada; G Caliendo; F Franconi; L J Ignarro; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

3.  Protective effect of an oestrogen against endotoxin-induced liver enzyme release.

Authors:  N J Carbarns; M L Neale; J M Stark
Journal:  Int J Exp Pathol       Date:  1993-06       Impact factor: 1.925

4.  Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.

Authors:  M Philpott; B C Baguley; L M Ching
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Prolongation of skin allografts by recombinant tumor necrosis factor and interleukin-1.

Authors:  G L Parenteau; G M Doherty; G R Peplinski; K Tsung; J A Norton
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

6.  Combination of inductive effect of lipopolysaccharide and in situ mechanical conditioning for forming an autologous vascular graft in vivo.

Authors:  Chao-Lin Chen; How-Ran Guo; Ying-Jan Wang; Hong-Tai Chang; Chui-Yi Pan; Ho-Yi Tuan-Mu; Hsiu-Chuan Lin; Chao-Yi Chen; Jin-Jia Hu
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

7.  Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia.

Authors:  M I Block; M Berg; M J McNamara; J A Norton; D L Fraker; H R Alexander
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.